BioSpace News Archive

Targeted drugs for breast and lung cancer could be used together to overcome resistance to treatment in several different tumour types, a new study shows.

According to reports, Novartis veteran Jonathan Symonds is likely to be named the next chairman of the board.

AMCA is an independent collection agency that CPL and many other entities used for debt collection. The incident is limited to AMCA’s systems.

FemPulse Corporation (FemPulse), a private, clinical-stage bioelectronic medicine company developing a novel therapy for the personalized treatment of overactive bladder (OAB) in women, announced today that the first participant has been enrolled in the Company’s clinical trial evaluating physiological responses to therapy delivered with the FemPulse System.

Production of new anti-cancer drugs at ADC Bio’s North Wales manufacturing plant has been boosted following completion of a new cleanroom facility, designed and built by WHP.

Mercom Capital Group, llc, a global communications and research firm, released its report on funding and mergers and acquisitions (M&A) activity for the Digital Health (Healthcare Information Technology) sector for the second quarter (Q2) and first half (1H) of 2019.

Gilt progeny (GP) often have restricted growth performance and health status in comparison to sow progeny (SP) from birth.

Mariem brings over 15 years’ experience in the Biopharmaceutical Industry, spent both advancing the clinical development and commercialisation of Infectious Disease products, and in delivering post-marketing monitoring of licensed medical products.

Arizona Applied Life Sciences and Technology Company Brings Aboard Top-Level Ag Sales Executives In New Positions to Enhance Company’s Global Presence

Administration of a non-sterile product intended to be sterile may result in serious and potentially life threatening infections or death.